FATE THERAPEUTICS INC FATE
FATE THERAPEUTICS INC statistics & valuation
Market cap$244.8M
P / S36.8×
P / B1.2×
Net margin-2051.1%
Return on equity-65.8%
FCF margin-1685.8%
Return on capital-52.2%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -2222.4% | -1542.6% | -299.9% | -320.2% | -388.6% | -407.5% | -943.1% | -1415.4% | -1025.9% | -726.1% |
| Net margin | -2051.1% | -1366.5% | -253.3% | -292.5% | -379.9% | -551.6% | -919.0% | -1405.0% | -1046.1% | -760.2% |
| FCF margin | -1685.8% | -906.8% | -217.9% | -294.7% | -382.4% | -140.5% | -848.0% | -864.0% | -940.8% | -687.9% |
| Return on assets | -42.7% | -42.3% | -31.8% | -39.9% | -23.0% | -27.9% | -32.5% | -31.3% | -40.8% | -35.2% |
| Return on equity | -65.8% | -58.4% | -43.7% | -58.2% | -31.3% | -45.1% | -40.1% | -41.5% | -55.6% | -45.7% |
| Debt / equity | — | — | — | — | — | — | — | 0.12× | 0.25× | 0.18× |
| Current ratio | 5.79 | 7.58 | 8.48 | 4.40 | 7.79 | 5.78 | 8.17 | 7.53 | 9.29 | 6.14 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.